<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364053">
  <stage>Registered</stage>
  <submitdate>14/04/2013</submitdate>
  <approvaldate>17/04/2013</approvaldate>
  <actrnumber>ACTRN12613000433707</actrnumber>
  <trial_identification>
    <studytitle>Effects of Ocular Angiography on Intraocular Pressure in Diabetic Patients</studytitle>
    <scientifictitle>Effects of Fundus Fluorescein Angiography Procedure on Intraocular Pressure and Ocular Pulse Amplitude in Non-Proliferative Diabetic Retinopathy Patients</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Non - proliferative diabetic retinopathy</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Florescein angiography
(Fluorescite 10% 5 ml Alcon Lab.)
intravenous administration (only once)
Duration of Fundus Fluorescein Angiography (FFA) procedure: 10 minutes
Duration of intravenous fluorescein injection: 2 seconds
FFA procedure occurs after 10 seconds from intravenous fluorescein injection</interventions>
    <comparator>The measurements were done before and after the fluorescein angiography in the same group (diabetic patients) 
This is a single group uncontrolled study </comparator>
    <control>Uncontrolled</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Intraocular pressure
Intraocular pressure (IOP) measurements were done with the Pascal dynamic contour tonometer (Pascal DCT, Swiss Microtechnology AG, Port, Switzerland). This is a slit-lamp biomicroscopy mounted, self-calibrating, 7-mm tip diameter, and 1.2-mm pressure sensor diameter device.</outcome>
      <timepoint>5 minutes after intravenous fluorescein dye injection</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Ocular pulse amplitude
Ocular pulse amplitude measurements were done with the Pascal dynamic contour tonometer (Pascal DCT, Swiss Microtechnology AG, Port, Switzerland).</outcome>
      <timepoint>5 minutes after intravenous fluorescein dye injection</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>intraocular pressure gender difference
This outcome was assessed by Pascal dynamic contour tonometer.</outcome>
      <timepoint>5 minutes after intravenous fluorescein dye injection</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>ocular pulse amplitude gender difference
This outcome was assessed by Pascal dynamic contour tonometer.</outcome>
      <timepoint>5 minutes after intravenous fluorescein dye injection</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Non-proliferative diabetic retinopathy patients</inclusivecriteria>
    <inclusiveminage>47</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Having any ocular disease other than non - proliferative diabetic retinopathy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods>paired samples t-test
Sample size was determined by looking at the t-test sample size table (alpha:0.05, beta:0.10, influence quantity:0.80). Also sample size was adjusted in order to perform a parametric statistical analysis.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>10/01/2013</anticipatedstartdate>
    <actualstartdate>11/01/2013</actualstartdate>
    <anticipatedenddate>1/03/2013</anticipatedenddate>
    <actualenddate>1/03/2013</actualenddate>
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Gokhan Pekel</primarysponsorname>
    <primarysponsoraddress>Camlaralti Mah., Kinikli, Pamukkale University, Ophthalmology Department, Denizli (postcode:20070)</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Pamukkale University</fundingname>
      <fundingaddress>Camlaralti Mah., Kinikli, Denizli (postcode:20070)</fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Ramazan Yagci</sponsorname>
      <sponsoraddress>Camlaralti Mah., Kinikli, Pamukkale University, Ophthalmology Department, Denizli (postcode:20070)</sponsoraddress>
      <sponsorcountry>Turkey</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>In this study, we evaluated the effects of fundus fluorescein angiography procedure, which has been performed for nearly 50 years in order to diagnose retina - choroidal diseases, on intraocular pressure and ocular pulse amplitude in non - proliferative diabetic patients.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Pamukkale University Ethics Committee</ethicname>
      <ethicaddress>Pamukkale University Faculty of Medicine, Camlaralti Mah., Kinikli, Denizli (postcode:20070)</ethicaddress>
      <ethicapprovaldate>25/12/2012</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>14/12/2012</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Gokhan Pekel</name>
      <address>Pamukkale University, Faculty of Medicine, Ophthalmology Department, Camlaralti Mah., Kinikli, Denizli (postcode:20070)</address>
      <phone>+90 258 4440728 - 5785</phone>
      <fax />
      <email>gkhanpekel@yahoo.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Gokhan Pekel</name>
      <address>Pamukkale University, Faculty of Medicine, Ophthalmology Department, Camlaralti Mah., Kinikli, Denizli (postcode:20070)</address>
      <phone>+90 258 4440728 - 5785</phone>
      <fax />
      <email>gkhanpekel@yahoo.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Gokhan Pekel</name>
      <address>Pamukkale University, Faculty of Medicine, Ophthalmology Department, Camlaralti Mah., Kinikli, Denizli (postcode:20070)</address>
      <phone>+90 258 4440728 - 5785</phone>
      <fax />
      <email>gkhanpekel@yahoo.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Gokhan Pekel</name>
      <address>Pamukkale University, Faculty of Medicine, Ophthalmology Department, Camlaralti Mah., Kinikli, Denizli (postcode:20070)</address>
      <phone>+90 258 4440728 - 5785</phone>
      <fax />
      <email>gkhanpekel@yahoo.com</email>
      <country>Turkey</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>